y2˜gzR-THP-COPi80ΞˆΘγƒCƒWƒ‡ƒEj(1“ϊŠΤj
€–Ϊ–Ό Šξ€—Κ ’PˆΚ }ަ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
‘S‘ΜƒXƒPƒWƒ…[ƒ‹ œ -- -- -- -- ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x
ƒŠƒcƒLƒVƒ}ƒu(R) 375 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒsƒmƒ‹ƒrƒ“(THP) 30 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒIƒ“ƒRƒrƒ“(VCR) 1 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒGƒ“ƒhƒLƒTƒ“(CPA) 500 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒvƒŒƒhƒjƒ“(PSL) 30 mg/‡u  -- -- -- >> @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
y’ˆΣƒ`ƒ…ƒEƒCŽ–€ƒWƒRƒEz